Skip to Main Content
Contribute Try STAT+ Today

As personnel moves go, the hiring of Amy Abernethy by Verily is about as big as it gets in digital health care. It signals the Alphabet-backed company’s ambition to fundamentally reshape clinical research, making participation easier and drugs more effective.

Abernethy, an oncologist by training, is credited with modernizing the way the Food and Drug Administration uses and manages data as the former number two at the agency. She essentially helped the FDA catch up, setting up standards for the use of real-world evidence and moving data in the cloud.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Create a display name to comment

This name will appear with your comment